Teva, Baxter Hit With $500M Damages In Hepatitis Case

Law360, New York (May 7, 2010, 6:40 PM EDT) -- U.S. subsidiaries of Teva Pharmaceuticals Industries Ltd. and Baxter International Inc. reportedly have been hit with a $500 million punitive damages award in the first suit among hundreds to go to trial after an outbreak of hepatitis C in 2008 that plaintiffs say was spread because vials of an anesthetic were mislabeled.

A jury handed down the award Friday in the Clark County District Court in Las Vegas, ordering Teva Parenteral Medicines Inc. to fork over $356 million and Baxter Healthcare Services to pay $144 million,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.